{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:15:13Z","timestamp":1788344113435,"version":"build-2803163510"},"reference-count":134,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.trre.2008.08.004","type":"journal-article","created":{"date-parts":[[2008,11,22]],"date-time":"2008-11-22T10:46:43Z","timestamp":1227350803000},"page":"34-46","source":"Crossref","is-referenced-by-count":108,"title":["Antibody-mediated rejection: treatment alternatives and outcomes"],"prefix":"10.1016","volume":"23","author":[{"given":"Neeraj","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Pirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Millie","family":"Samaniego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2008.08.004_bib1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/01.TP.0000129256.84027.D6","article-title":"Consensus opinion from the antibody working group on the diagnosis, reporting, and risk assessment for antibody-mediated rejection and desensitization protocols","volume":"7","author":"Montgomery","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib2","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/j.1600-6143.2004.00500.x","article-title":"National conference to assess antibody-mediated rejection in solid organ transplantation","volume":"4","author":"Takemoto","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2008.08.004_bib3","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1034\/j.1600-6143.2003.00072.x","article-title":"Antibody-mediated rejection criteria\u2014an addition to the Banff'97 classification of renal allograft rejection","volume":"3","author":"Racusen","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2008.08.004_bib4","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1097\/00007890-200103150-00013","article-title":"Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics","volume":"71","author":"Crespo","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib5","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/01.TP.0000060252.57111.AC","article-title":"Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection","volume":"75","author":"Rocha","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib6","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1097\/01.TP.0000122187.76518.BC","article-title":"Treatment of C4d-positive acute humoral rejection with plasmapheresis and rabbit polyclonal antithymocyte globulin","volume":"77","author":"Shah","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib7","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1097\/00007890-199812150-00008","article-title":"Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation","volume":"66","author":"Pascual","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/00007890-199801270-00014","article-title":"Long-term results of ABO-incompatible living kidney transplantation: a single-center experience","volume":"65","author":"Tanabe","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib9","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/01.TP.0000080685.31697.FC","article-title":"Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients","volume":"76","author":"Jordan","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib10","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1034\/j.1600-6143.2003.00180.x","article-title":"Overcoming a positive crossmatch in living-donor kidney transplantation","volume":"3","author":"Gloor","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2008.08.004_bib11","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1097\/01.TP.0000058226.39732.32","article-title":"ABO-incompatible kidney transplantation using both A2 and non-A2 living donors","volume":"75","author":"Gloor","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib12","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00007890-200009270-00006","article-title":"Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients","volume":"70","author":"Montgomery","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib13","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1097\/00007890-200011270-00023","article-title":"A high panel reactive antibody rescue protocol for cross-match-positive live donor kidney transplants","volume":"70","author":"Schweitzer","year":"2000","journal-title":"Transplatation"},{"key":"10.1016\/j.trre.2008.08.004_bib14","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1034\/j.1600-6143.2003.00135.x","article-title":"Humoral theory of transplantation","volume":"3","author":"Terasaki","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2008.08.004_bib15","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of the positive crossmatch test in kidney transplantation","volume":"280","author":"Patel","year":"1969","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2008.08.004_bib16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJM197001152820301","article-title":"Humoral antibodies in renal allotransplantation in man","volume":"282","author":"Jeannet","year":"1970","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2008.08.004_bib17","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1600-6143.2004.00360.x","article-title":"Predicting kidney graft failure by HLA antibodies: a prospective trial","volume":"4","author":"Terasaki","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2008.08.004_bib18","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1681\/ASN.2004121130","article-title":"Frequency and clinical implications of development of donor-specific and non-donor specific HLA antibodies after kidney transplantation","volume":"16","author":"Hourmant","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2008.08.004_bib19","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/00007890-200210270-00025","article-title":"All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies","volume":"74","author":"Lee","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib20","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1681\/ASN.V123574","article-title":"Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries","volume":"12","author":"Mauiyyedi","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2008.08.004_bib21","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-6143.2006.01688.x","article-title":"Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (CAN)","volume":"7","author":"Solez","year":"2007","journal-title":"Am J Transplant"},{"issue":"Suppl 1","key":"10.1016\/j.trre.2008.08.004_bib22","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1399-0039.2006.00765.x","article-title":"14th International HLA and Immunogenetics Workshop: report on the prospective chronic rejection project","volume":"69","author":"Ozawa","year":"2007","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.trre.2008.08.004_bib23","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1681\/ASN.V1341091","article-title":"Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury","volume":"13","author":"Bohmig","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2008.08.004_bib24","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1523-1755.1999.00299.x","article-title":"The Banff 97 working classification of renal allograft pathology","volume":"55","author":"Racusen","year":"1999","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2008.08.004_bib25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00007890-200107150-00016","article-title":"Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection","volume":"72","author":"Theruvath","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib26","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/S0041-1345(02)03039-7","article-title":"Successful results after 3 years' tacrolimus immunosuppression in ABO-incompatible kidney transplantation recipients in Japan","volume":"34","author":"Takahashi","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2008.08.004_bib27","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1097\/01.TP.0000084200.40159.EC","article-title":"Intravenous immunoglobulin and thymoglobulin facilitate kidney transplantation in complement-dependent cytotoxicity B-cell and flow cytometry T- or B-cell crossmatch-positive patients","volume":"76","author":"Akalin","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib28","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/00007890-200211150-00001","article-title":"Successful A1-to O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double filtration plasmapheresis","volume":"74","author":"Sawada","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1399-0012.1997.tb00814.x","article-title":"Reversal of accelerated renal allograft rejection with FK506","volume":"11","author":"Woodle","year":"1997","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2008.08.004_bib30","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/S0041-1345(97)00317-5","article-title":"Removal of pre-formed cytotoxic antibody using Prosorba (Staph Protein-A-Silica) column without immunosuppression","volume":"29","author":"Burke","year":"1997","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2008.08.004_bib31","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1600-6143.2004.00364.x","article-title":"Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriers","volume":"4","author":"Warren","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2008.08.004_bib32","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/1098-1101(2000)15:3<180::AID-JCA5>3.0.CO;2-6","article-title":"Treatment of antibody-mediated accelerated rejection using plasmapheresis","volume":"15","author":"Madan","year":"2000","journal-title":"J Clin Apheresis"},{"key":"10.1016\/j.trre.2008.08.004_bib33","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1097\/01.tp.0000184622.69708.c1","article-title":"A comparison of splenectomy versus intensive post-transplant antidonor blood group antibody monitoring without splenectomy in ABO-incompatible kidney transplantation","volume":"80","author":"Gloor","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib34","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.transproceed.2004.12.251","article-title":"Combined therapy of deoxyspergualin and plasmapheresis: a useful treatment for antibody-mediated acute rejection after kidney transplantation","volume":"37","author":"Nojima","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2008.08.004_bib35","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/00007890-199809270-00017","article-title":"Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action","volume":"66","author":"Jordan","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib36","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1399-3046.2005.00363.x","article-title":"Current approaches to treatment of antibody-mediated rejection","volume":"9","author":"Jordan","year":"2005","journal-title":"Pediatr Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib37","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1600-6143.2004.00454.x","article-title":"Rituximab as treatment for refractory kidney transplant rejection","volume":"4","author":"Becker","year":"2004","journal-title":"Am J Transplant"},{"issue":"Suppl 8","key":"10.1016\/j.trre.2008.08.004_bib38","first-page":"258","article-title":"Anti-CD20 rescue therapy for kidneys undergoing antibody-mediated rejection","volume":"4","author":"Montgomery","year":"2004","journal-title":"Am J Transplant"},{"issue":"Suppl 3","key":"10.1016\/j.trre.2008.08.004_bib39","first-page":"259","article-title":"Early allograft outcomes in patients with antibody mediated rejection treated with rituximab: a single center experience","volume":"2","author":"Samaniego","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2008.08.004_bib40","first-page":"199","article-title":"Renal transplantation at the Johns Hopkins Comprehensive Transplant Center","author":"Montgomery","year":"2003","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2008.08.004_bib41","series-title":"Cellular and molecular immunology","author":"Abbas","year":"2003"},{"key":"10.1016\/j.trre.2008.08.004_bib42","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/00007890-199103000-00024","article-title":"Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins","volume":"51","author":"Bonnefoy-Berard","year":"1991","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib43","first-page":"435","article-title":"Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3","volume":"15","author":"Bonnefoy-Berard","year":"1996","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2008.08.004_bib44","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1097\/01.TP.0000164159.20075.16","article-title":"Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways","volume":"79","author":"Zand","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib45","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1182\/blood-2005-06-2269","article-title":"Apoptosis and complement-mediated lysis of myeloma cells by polyclonal rabbit antithymocyte globulin","volume":"107","author":"Zand","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.trre.2008.08.004_bib46","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.exphem.2005.08.004","article-title":"Antithymocyte globulin induces complement-dependent cell lysis and caspase-dependent apoptosis in myeloma cells","volume":"33","author":"Ayuk","year":"2005","journal-title":"Exp Hematol"},{"key":"10.1016\/j.trre.2008.08.004_bib47","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1432-2277.2005.00249.x","article-title":"Characterization of rejection episodes in patients following positive crossmatch and ABO-incompatible live donor renal transplantation","volume":"19","author":"Kayler","year":"2006","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2008.08.004_bib48","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanisms of action","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.trre.2008.08.004_bib49","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/00007890-200210270-00023","article-title":"Mycophenolate mofetil suppresses the production of anti-blood type antibodies after renal transplantation across the ABO blood barrier: ELISA to detect humoral activity","volume":"74","author":"Ishida","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib50","doi-asserted-by":"crossref","first-page":"417","DOI":"10.5414\/CNP63417","article-title":"Implication of the peak serum level of mizoribine for control of the serum anti-dsDNA antibody titer in patients with lupus nephritis","volume":"63","author":"Tanaka","year":"2005","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.trre.2008.08.004_bib51","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1432-2277.2004.00042.x","article-title":"Potential value of high-dose mizoribine as rescue therapy for ongoing acute humoral rejection","volume":"18","author":"Liu","year":"2005","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2008.08.004_bib52","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/ard.59.11.841","article-title":"Leflunomide: mode of action in the treatment of rheumatoid arthritis","volume":"59","author":"Breedveld","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trre.2008.08.004_bib53","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1523-1755.2001.00460.x","article-title":"Rapamycin in transplantation: a review of the evidence","volume":"59","author":"Saunders","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/j.trre.2008.08.004_bib54","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1002\/eji.1830201017","article-title":"Suppression of B cell activation by cyclosporin A, FK506 and rapamycin","volume":"20","author":"Wicker","year":"1990","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.trre.2008.08.004_bib55","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1006\/cimm.1994.1193","article-title":"Inhibition of human B lymphocyte cell cycle progression and differentiation by rapamycin","volume":"156","author":"Aagaard-Tillery","year":"1994","journal-title":"Cell Immunol"},{"key":"10.1016\/j.trre.2008.08.004_bib56","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1034\/j.1399-3062.2000.020306.x","article-title":"Significant post-transplant hypogammaglobulinemia in six heart transplant recipients: an emerging clinical phenomenon","volume":"2","author":"Corales","year":"2000","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.trre.2008.08.004_bib57","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1164\/rccm.200510-1609OC","article-title":"Immunoglobulin G levels before and after lung transplantation","volume":"173","author":"Yip","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.trre.2008.08.004_bib58","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/35001102","article-title":"How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis","volume":"403","author":"Glynne","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.trre.2008.08.004_bib59","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/00007890-199106000-00018","article-title":"The effects of immunosuppressive agents on in vitro production of human immunoglobulins","volume":"51","author":"Stevens","year":"1991","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib60","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0165-2478(93)90053-5","article-title":"Cyclosporin A and FK506 block the negative signaling mediated by surface IgM cross-linking in normal human mature B cells","volume":"36","author":"Yamaoka","year":"1993","journal-title":"Immunol Lett"},{"key":"10.1016\/j.trre.2008.08.004_bib61","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/00007890-199212000-00016","article-title":"The distinct effects of FK506 on the activation, proliferation, and differentiation of human B lymphocytes","volume":"54","author":"Morikawa","year":"1992","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib62","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0041-1345(02)03856-3","article-title":"Double filtration plasmapheresis in an ABO-incompatible renal transplantation: a case report","volume":"35","author":"Kawamura","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2008.08.004_bib63","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1681\/ASN.V12112482","article-title":"C4d-positive acute humoral renal allograft rejection: effective treatment by immunoadsorption","volume":"12","author":"Bohmig","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2008.08.004_bib64","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/01.TP.0000078622.43689.D4","article-title":"Successful ABO-incompatible kidney transplantations without splenectomy using antigen-specific immunoadsorption and rituximab","volume":"76","author":"Tyden","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib65","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1046\/j.1526-0968.2002.00429.x","article-title":"Plasma adsorption in critical care","volume":"6","author":"Yang","year":"2002","journal-title":"Ther Apher"},{"key":"10.1016\/j.trre.2008.08.004_bib66","first-page":"1","article-title":"West Nile Virus encephalitis in a kidney transplant recipient","author":"Shepherd","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2008.08.004_bib67","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0955-3886(90)90028-H","article-title":"Therapeutic protein A immunoadsorption. A review","volume":"11","author":"Gjorstrup","year":"1990","journal-title":"Transfusion Science"},{"key":"10.1016\/j.trre.2008.08.004_bib68","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1365-3148.2001.00313.x","article-title":"ABO-incompatibility in solid organ transplantation","volume":"11","author":"Rydberg","year":"2001","journal-title":"Transfusion Med"},{"key":"10.1016\/j.trre.2008.08.004_bib69","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0272-6386(00)70014-X","article-title":"Role of humoral immune reactions as target for antirejection therapy in recipients of a spousal-donor kidney graft","volume":"35","author":"Bohmig","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2008.08.004_bib70","first-page":"240","article-title":"The Prosorba column for treatment of refractory rheumatoid arthritis: a randomized, double-blind, sham-controlled trial","volume":"3","author":"Falson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trre.2008.08.004_bib71","first-page":"804","article-title":"Treatment of patients with refractory rheumatoid arthritis with extracorporeal protein A immnoadsorption column: a pilot trial","volume":"21","author":"Wiesenhuter","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1016\/j.trre.2008.08.004_bib72","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1046\/j.1526-0968.2003.00101.x","article-title":"Plamapheresis in C4d-positive acute humoral rejection following kidney transplantation: a review of 4 cases","volume":"7","author":"Lennertz","year":"2003","journal-title":"Ther Apher & Dial"},{"key":"10.1016\/j.trre.2008.08.004_bib73","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.transproceed.2004.07.071","article-title":"C4d-positive acute humoral renal allograft rejection: rescue therapy by immunoadsorption in combination with tacrolimus and mycophenolate mofetil","volume":"36","author":"Liu","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2008.08.004_bib74","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1034\/j.1600-6143.2003.00121.x","article-title":"Utility of intravenous immune globulin in kidney transplantation: efficacy, safety and cost implications","volume":"3","author":"Jordan","year":"2003","journal-title":"Am J Transplant"},{"issue":"Suppl 4","key":"10.1016\/j.trre.2008.08.004_bib75","doi-asserted-by":"crossref","first-page":"s111","DOI":"10.1067\/mai.2001.117824","article-title":"Antibody-directed therapy: past, present, and future","volume":"108","author":"Gelfand","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.trre.2008.08.004_bib76","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJM199901213400311","article-title":"Mechanisms of intravenous immune globulin therapy in antibody-mediated autoimmune diseases","volume":"340","author":"Yu","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2008.08.004_bib77","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","article-title":"Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin","volume":"345","author":"Kazatchkine","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2008.08.004_bib78","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1182\/blood.V100.3.1055","article-title":"Gamma-globulins prepared form sera of multiparous women bind anti-HLA antibodies and inhibit an established in vivo human alloimmune response","volume":"100","author":"Semple","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.trre.2008.08.004_bib79","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1111\/j.1600-6143.2005.01056.x","article-title":"IVIG and HLA antibodies. Evidence for inhibition of complement activation but not for anti-idiotypic activity","volume":"5","author":"Watanabe","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2008.08.004_bib80","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1385\/CRIAI:29:3:185","article-title":"Facing the enigma of immunomodulatory effects of intravenous immunoglobulin","volume":"29","author":"Sapir","year":"2005","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.trre.2008.08.004_bib81","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1600-6143.2005.01214.x","article-title":"Intravenous Gammaglobulin (IVIG): a novel approach to improve transplant rates and outcomes in highly HLA-sensitized patients","volume":"6","author":"Jordan","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2008.08.004_bib82","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1097\/00007890-200105270-00014","article-title":"Differential inhibitory effects of intravenous immunoglobulin preparations on HLA-alloantibodies in vitro","volume":"71","author":"Wassmuth","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib83","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/BF00919386","article-title":"Long-term use of IgA-depleted intravenous immunoglobulin in immunodeficient subjects with anti-IgA antibodies","volume":"13","author":"Cunningham-Rundles","year":"1993","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.trre.2008.08.004_bib84","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1592\/phco.2005.25.6.886","article-title":"Intravenous immunoglobulin-associated acute renal failure: case series and literature review","volume":"25","author":"Itkin","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.trre.2008.08.004_bib85","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000104424","article-title":"Acute renal failure, translocational hyponatremia and hyperkalemia following intravenous immunoglobulin therapy","volume":"106","author":"Daphnis","year":"2007","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.trre.2008.08.004_bib86","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0272-6386(95)90003-9","article-title":"Acute renal failure associated with immunoglobulin therapy","volume":"25","author":"Cantu","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2008.08.004_bib87","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1399-3046.2004.00214.x","article-title":"Transplanting patients with a positive donor-specific crossmatch: a single center's perspective","volume":"8","author":"Montgomery","year":"2004","journal-title":"Pediatr Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib88","first-page":"256","article-title":"A four year follow-up of rejection patterns, treatment and outcomes in highly-HLA sensitized crossmatch positive patients transplanted with IVIg desensitization (Abstract)","volume":"4","author":"Jordan","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2008.08.004_bib89","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2215\/CJN.01651105","article-title":"Presensitization: the problem and its management","volume":"1","author":"Jordan","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2008.08.004_bib90","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1600-6143.2006.01709.x","article-title":"The utility of splenectomy as rescue treatment for severe acute antibody mediated rejection","volume":"7","author":"Locke","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2008.08.004_bib91","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/01.tp.0000243739.31440.2b","article-title":"Successful rescue of refractory, severe antibody mediated rejection with splenectomy","volume":"83","author":"Kaplan","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib92","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1111\/j.1600-6143.2006.01356.x","article-title":"C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: correlation with histologic findings","volume":"6","author":"Haas","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2008.08.004_bib93","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1600-6143.2006.01657.x","article-title":"Subclinical acute antibody-mediated rejection in positive crossmatch renal allografts","volume":"7","author":"Haas","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2008.08.004_bib94","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1111\/j.1600-6143.2007.01895.x","article-title":"Transplant glomerulopathy: subclinical incidence and association with alloantibody","volume":"7","author":"Gloor","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2008.08.004_bib95","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1600-6143.2005.01178.x","article-title":"A comparison of plasmapheresis versus high-dose IVIg desensitization in renal allograft recipients with high levels of donor specific alloantibody","volume":"6","author":"Stegall","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2008.08.004_bib96","first-page":"195","article-title":"The CD20 surface molecule of B lymphocytes functions as a calcium channel","volume":"14 D","author":"Tedder","year":"1990","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.trre.2008.08.004_bib97","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1200\/JCO.2003.05.013","article-title":"Two immunoglobulin G fragment C receptor polymorphisms independently predict responses to rituximab in patients with follicular lymphoma","volume":"21","author":"Weng","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.trre.2008.08.004_bib98","doi-asserted-by":"crossref","first-page":"817","DOI":"10.4049\/jimmunol.174.2.817","article-title":"Importance of cellular microenvironment and circulatory dynamics in B cell immunotherapy","volume":"174","author":"Gong","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.trre.2008.08.004_bib99","first-page":"918","article-title":"Rituximab reduces the number of peripheral blood B-cells in vitro mainly by effector cell-mediated mechanisms","volume":"87","author":"Voso","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.trre.2008.08.004_bib100","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/blood.V99.3.754","article-title":"Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor Fc-gamma-R IIIa gene","volume":"99","author":"Cartron","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.trre.2008.08.004_bib101","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/art.10764","article-title":"The relationship of FcgammaRIIIa genotype to degree of B cell depletion by rituximab in the treatment of systemic lupus erythematosus","volume":"48","author":"Anolik","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trre.2008.08.004_bib102","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00002371-200105000-00011","article-title":"Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies","volume":"24","author":"Treon","year":"2001","journal-title":"J Immunother"},{"issue":"Suppl 2","key":"10.1016\/j.trre.2008.08.004_bib103","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00001813-200211002-00002","article-title":"Mechanism of action of rituximab","volume":"13","author":"Cerny","year":"2002","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.trre.2008.08.004_bib104","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1600-6143.2004.00507.x","article-title":"Plasmapheresis, CMV Hyperimmune Globulin and anti-CD20 allow ABO-incompatible renal transplantatio without splenectomy","volume":"4","author":"Sonnenday","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2008.08.004_bib105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-6143.2004.00653.x","article-title":"ABO kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab","volume":"5","author":"Tyden","year":"2005","journal-title":"Am J Transplant"},{"issue":"World Transplant Congress 2006","key":"10.1016\/j.trre.2008.08.004_bib106","first-page":"259","article-title":"Incidence and outcomes of treatment protocols for antibody-mediated rejection in highly sensitized patients transplanted using desensitization therapy","author":"Peng","year":"2006","journal-title":"Am J Transplant and Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib107","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1600-6143.2005.01185.x","article-title":"Antibody-mediated rejection of a pancreas allograft","volume":"6","author":"Melcher","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2008.08.004_bib108","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0003-4975(02)03824-9","article-title":"Treatment of humoral rejection with rituximab","volume":"74","author":"Garrett","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.trre.2008.08.004_bib109","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.1016\/j.transproceed.2004.10.087","article-title":"Refractory humoral cardiac allograft rejection successfully treated with a single dose of rituximab","volume":"36","author":"Baran","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2008.08.004_bib110","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/01.tp.0000261113.30757.d1","article-title":"Rituximab therapy for acute humoral rejection after kidney transplantation","volume":"83","author":"Faguer","year":"2007","journal-title":"Transplantation"},{"issue":"WTC supplement","key":"10.1016\/j.trre.2008.08.004_bib111","first-page":"122","article-title":"Monitoring for infectious complications of Campath 1H and Rituxan induction therapy in crossmatch positive kidney transplant patients receiving intravenous gammaglobulin desensitization (Abstract)","author":"Vo","year":"2006","journal-title":"Am J Transplant and Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib112","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/ni1201-1103","article-title":"Plasma cells: finding new light at the end of B cell development","volume":"2","author":"Calame","year":"2001","journal-title":"Nature Immunol"},{"key":"10.1016\/j.trre.2008.08.004_bib113","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.coi.2004.02.001","article-title":"Plasma cell differentiation and multiple myeloma","volume":"16","author":"Shapiro-Shelef","year":"2004","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.trre.2008.08.004_bib114","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1002\/art.22019","article-title":"Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis","volume":"54","author":"Roll","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trre.2008.08.004_bib115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3233\/HAB-2004-13301","article-title":"In vivo human B-cell subset recovery after in vivo depletion with rituximab, anti-human CD20 monoclonal antibody","volume":"13","author":"Sidner","year":"2004","journal-title":"Hum Antibodies"},{"key":"10.1016\/j.trre.2008.08.004_bib116","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/clim.2000.4980","article-title":"Hapten-induced primary and memory humoral responses are inhibited by the infusion of anti-CD20 monoclonal antibody (IDEC-C2B8, Rituximab)","volume":"98","author":"Gonzalez-Stawinski","year":"2001","journal-title":"Clin Immunol"},{"key":"10.1016\/j.trre.2008.08.004_bib117","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2141.2007.06584.x","article-title":"Delayed redistribution of CD27, CD40 and CD80 positive B cells and the impaired in vitro immunoglobulin production in patients with non-Hodgkin lymphoma after rituximab treatment as an adjuvant to autologous stem cell transplantation","volume":"137","author":"Nishio","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.trre.2008.08.004_bib118","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/sj.bmt.1705463","article-title":"Adjuvant rituximab causes prolonged hypogammaglobulinemia following autologous stem cell transplant for non-Hodgkin's lymphoma","volume":"38","author":"Shortt","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.trre.2008.08.004_bib119","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.bmt.1704307","article-title":"Prolonged hypogammaglobulinemia following rituximab treatment for post-transplant Epstein-Barr virus-associated lymphoproliferative disease","volume":"33","author":"Imashuku","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.trre.2008.08.004_bib120","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/01.TP.0000112934.12622.2B","article-title":"Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics and pharmacokinetics","volume":"77","author":"Vieira","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib121","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/74704","article-title":"Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets","volume":"6","author":"Clynes","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.trre.2008.08.004_bib122","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1126\/science.1118948","article-title":"Divergent immunoglobulin G subclass activity through selective Fc receptor binding","volume":"310","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.trre.2008.08.004_bib123","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1097\/01.tp.0000183749.79424.b4","article-title":"Rituximab therapy for the novo mixed cryoglobulinemia in renal transplant patients","volume":"80","author":"Basse","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib124","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1097\/01.ASN.0000071511.35221.B3","article-title":"Rituximab in idiopathic membranous nephropathy: a one-year prospective study","volume":"14","author":"Ruggenenti","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trre.2008.08.004_bib125","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0140-6736(02)11042-7","article-title":"Rituximab for idiopathic membranous nephropathy","volume":"360","author":"Remuzzi","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.trre.2008.08.004_bib126","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/art.20858","article-title":"Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trial","volume":"52","author":"Sfikakis","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trre.2008.08.004_bib127","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1365-2796.2005.01494.x","article-title":"Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab","volume":"257","author":"Eriksson","year":"2005","journal-title":"J Intern Med"},{"key":"10.1016\/j.trre.2008.08.004_bib128","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/art.20718","article-title":"Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"Keogh","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trre.2008.08.004_bib129","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1053\/j.ajkd.2003.12.057","article-title":"Anti-CD20 monoclonal antibody (rituximab) treatment for hepatitis C-negative therapy resistant essential mixed cryoglobulinemia with renal and cardiac failure","volume":"43","author":"Ghijsels","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.trre.2008.08.004_bib130","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/01.TP.0000151632.21551.00","article-title":"Mycophenolate mofetil substitution for cyclosporine A in renal transplant recipients with chronic progressive allograft dysfunction: the \u201ccreeping creatinine\u201d study","volume":"79","author":"Dudley","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib131","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00007890-199701150-00008","article-title":"Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups","volume":"63","author":"Halloran","year":"1997","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2008.08.004_bib132","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2165\/00003495-199651020-00007","article-title":"Mycophenolate mofetil: a review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation","volume":"51","author":"Fulton","year":"1996","journal-title":"Drugs"},{"key":"10.1016\/j.trre.2008.08.004_bib133","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1056\/NEJMra033540","article-title":"Immunosuppressive drugs for kidney transplantation","volume":"351","author":"Halloran","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2008.08.004_bib134","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00508-006-0531-3","article-title":"Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathy","volume":"118","author":"Schwarz","year":"2006","journal-title":"Wien Klin Wochenschr"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X08000839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X08000839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T04:28:09Z","timestamp":1738556889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X08000839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":134,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0955470X08000839"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2008.08.004","relation":{},"ISSN":["0955-470X"],"issn-type":[{"value":"0955-470X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}